Manufacturer of Controlled Substances; Notice of Application, 70985 [E6-20694]

Download as PDF 70985 Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Application Manufacturer of Controlled Substances; Notice of Registration By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48945), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and II: Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 24, 2006, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I: By Notice dated June 9, 2006, and published in the Federal Register on June 19, 2006, (71 FR 35310—35311), Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Heroin (9200) ................................ Cocaine (9041) ............................. Codeine (9050) ............................. Meperidine (9230) ......................... Methadone (9250) ........................ Morphine (9300) ........................... Marihuana (7360) .............................. Tetrahydrocannabinols (7370) .......... I II II II II II The company plans to import these controlled substances for the manufacture of reference standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Applied Science Labs to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Applied Science Labs to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. sroberts on PROD1PC70 with NOTICES Schedule Drug Schedule Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20747 Filed 12–6–06; 8:45 am] I I The company plans to manufacture small quantities of marihuana derivatives for research purposes. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol. In reference to drug code 7370 (Tetrahydrocannabinols), the company will manufacture a synthetic THC. No other activity for this drug code is authorized for registration. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/ODL; or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than February 5, 2007. Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20694 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P Drug Tetrahydrocannabinols (7370) ..... Dihydromorphine (9145) ............... Oxycodone (9143) ........................ Hydrocodone (9193) ..................... Hydromorphone (9150) ................ 18:18 Dec 06, 2006 Jkt 211001 PO 00000 No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20690 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P Frm 00040 Fmt 4703 Sfmt 4703 I I II II II The firm plans to manufacture the listed controlled substances in bulk for distribution to its customers. By letter dated September 5, 2006, the company has withdrawn their request for the addition of Methylphenidate (1724), to their application for registration. BILLING CODE 4410–09–P VerDate Aug<31>2005 Schedule E:\FR\FM\07DEN1.SGM 07DEN1

Agencies

[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Page 70985]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20694]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 24, 2006, Cayman 
Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedule I:

------------------------------------------------------------------------
                     Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360).............................  I
Tetrahydrocannabinols (7370).................  I
------------------------------------------------------------------------

    The company plans to manufacture small quantities of marihuana 
derivatives for research purposes. In reference to drug code 7360 
(Marihuana), the company plans to bulk manufacture cannabidiol. In 
reference to drug code 7370 (Tetrahydrocannabinols), the company will 
manufacture a synthetic THC. No other activity for this drug code is 
authorized for registration.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than February 5, 2007.

    Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-20694 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P